关注
Elena Bartoloni Bocci
Elena Bartoloni Bocci
Ricercatore universitario, Università di Perugia
在 unipg.it 的电子邮件经过验证
标题
引用次数
引用次数
年份
CD4+ CD28− T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients
R Gerli, G Schillaci, A Giordano, EB Bocci, O Bistoni, G Vaudo, ...
Circulation 109 (22), 2744-2748, 2004
3392004
Defining disease activity states and clinically meaningful improvement in primary Sjögren's syndrome with EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient …
R Seror, H Bootsma, A Saraux, SJ Bowman, E Theander, JG Brun, ...
Annals of the rheumatic diseases 75 (2), 382-389, 2016
3312016
Validation of EULAR primary Sjögren's syndrome disease activity (ESSDAI) and patient indexes (ESSPRI)
R Seror, E Theander, JG Brun, M Ramos-Casals, V Valim, T Dörner, ...
Annals of the rheumatic diseases 74 (5), 859-866, 2015
3092015
Primary Sjögren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients
C Baldini, P Pepe, L Quartuccio, R Priori, E Bartoloni, A Alunno, ...
Rheumatology 53 (5), 839-844, 2014
2972014
COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy
C Perricone, E Bartoloni, R Bursi, G Cafaro, GM Guidelli, Y Shoenfeld, ...
Immunologic research 68, 213-224, 2020
2312020
Balance between regulatory T and Th17 cells in systemic lupus erythematosus: the old and the new
A Alunno, E Bartoloni, O Bistoni, G Nocentini, S Ronchetti, S Caterbi, ...
Journal of Immunology Research 2012 (1), 823085, 2012
1922012
Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data …
P Brito-Zerón, N Acar-Denizli, M Zeher, A Rasmussen, R Seror, ...
Annals of the rheumatic diseases 76 (6), 1042-1050, 2017
1912017
Clinical spectrum time course in anti Jo-1 positive antisynthetase syndrome: results from an international retrospective multicenter study
L Cavagna, L Nuno, CA Scire, M Govoni, FJL Longo, F Franceschini, ...
Medicine 94 (32), e1144, 2015
1852015
Precocious intima‐media thickening in patients with primary Sjögren's syndrome
G Vaudo, EB Bocci, Y Shoenfeld, G Schillaci, R Wu, N Del Papa, C Vitali, ...
Arthritis & Rheumatism 52 (12), 3890-3897, 2005
1852005
How immunological profile drives clinical phenotype of primary Sjogren's syndrome at diagnosis: analysis of 10,500 patients (Sjogren Big Data Project)
P Brito-Zerón, N Acar-Denizli, WF Ng, M Zeher, A Rasmussen, T Mandl, ...
Clinical and experimental rheumatology 36 (3), S102-S112, 2018
1802018
Biomarkers of lymphoma in Sjögren’s syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study
L Quartuccio, M Isola, C Baldini, R Priori, EB Bocci, F Carubbi, M Maset, ...
Journal of autoimmunity 51, 75-80, 2014
1792014
Cardiovascular disease risk burden in primary Sjögren's syndrome: results of a population‐based multicentre cohort study
E Bartoloni, C Baldini, G Schillaci, L Quartuccio, R Priori, F Carubbi, V Bini, ...
Journal of internal medicine 278 (2), 185-192, 2015
1772015
Influence of antisynthetase antibodies specificities on antisynthetase syndrome clinical spectrum time course
L Cavagna, E Trallero-Araguás, F Meloni, I Cavazzana, J Rojas-Serrano, ...
Journal of clinical medicine 8 (11), 2013, 2019
1732019
COVID-19: the new challenge for rheumatologists.
F Ferro, E Elefante, C Baldini, E Bartoloni, I Puxeddu, R Talarico, ...
Clinical and experimental rheumatology 38 (2), 175-180, 2020
1662020
The anti-viral facet of anti-rheumatic drugs: Lessons from COVID-19
C Perricone, P Triggianese, E Bartoloni, G Cafaro, AF Bonifacio, R Bursi, ...
Journal of Autoimmunity 111, 102468, 2020
1542020
Altered immunoregulation in rheumatoid arthritis: the role of regulatory T cells and proinflammatory Th17 cells and therapeutic implications
A Alunno, M Manetti, S Caterbi, L Ibba-Manneschi, O Bistoni, E Bartoloni, ...
Mediators of inflammation 2015 (1), 751793, 2015
1502015
Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis
R Gerli, EB Bocci, Y Sherer, G Vaudo, S Moscatelli, Y Shoenfeld
Annals of the rheumatic diseases 67 (5), 724-725, 2008
1492008
Efficacy and safety of off-label use of rituximab in refractory lupus: data from the Italian Multicentre Registry
L Iaccarino, E Bartoloni, L Carli, F Ceccarelli, F Conti, S De Vita, ...
Clinical and experimental rheumatology 33 (4), 449-456, 2015
1382015
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis …
R Giacomelli, A Afeltra, A Alunno, C Baldini, E Bartoloni-Bocci, ...
Autoimmunity Reviews 16 (9), 911-924, 2017
1362017
Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin
E Bartoloni, Y Shoenfeld, R Gerli
Arthritis care & research 63 (2), 178-183, 2011
1342011
系统目前无法执行此操作,请稍后再试。
文章 1–20